Literature DB >> 21468570

Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells.

Jun Peng1, Youqin Chen, Jiumao Lin, Qunchuan Zhuang, Wei Xu, Zhenfeng Hong, Thomas J Sferra.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) plays an important role in tumor cell survival and proliferation and thus has become a major focus in the development of anti-cancer therapies. Patrinia scabiosaefolia has been used for the treatment of various types of cancer. However, the precise mechanism of the anti-cancer activity of Patrinia scabiosaefolia remains unclear. In this study, we evaluated the effect of the ethanol extract of Patrinia scabiosaefolia (EEPS) on proliferation and apoptosis in human multiple myeloma U266 cells that persistently express phosphorylated STAT3, and investigated the possible molecular mechanisms mediating its biological effects. We found that EEPS inhibited the phosphorylation of STAT3 in U266 cells. Consequently, the inhibitory effect of EEPS on STAT3 activation resulted in the suppression of cell proliferation and the induction of cell apoptosis. Moreover, EEPS treatment inhibited the expression of cyclin D1 (a promoter of cell proliferation) and Bcl-2 (an inhibitor of apoptosis), two important target genes of the STAT3 signaling pathway. Our findings for the first time demonstrate that Patrinia scabiosaefolia inhibits proliferation and promotes the apoptosis of cancer cells via inhibition of the STAT3 pathway, which may in part explain its anti-cancer activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468570     DOI: 10.3892/mmr.2011.413

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Scientific research at Fujian Academy of Integrative Medicine: current status and future directions.

Authors:  Xian-xiang Liu; Jin-zhong Wu; Yan-ping Lin; Zhi-yun Cao; Jun Peng; Jing Cai; Chun-jiang Tan; Lian-ming Liao; Jian Du
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

2.  [Inhibitory effect of giganteaside D on hepatocellular carcinoma Hep 3b cells and the underlying mechanisms].

Authors:  Shu-Wen Xie; Yan-Ni Wang; Hui-Yan Luo; Zi-Bin Lu; Lin-Zhong Yu; Jun-Shan Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

3.  Chemical Composition, Anticancer, Anti-neuroinflammatory, and Antioxidant Activities of the Essential Oil of Patrinia scabiosaefolia.

Authors:  Jing Lin; Qiao-Yan Cai; Wen Xu; Jiu-Mao Lin; Jun Peng
Journal:  Chin J Integr Med       Date:  2016-09-01       Impact factor: 1.978

4.  Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.

Authors:  Junshan Liu; Xiduan Wei; Yafeng Wu; Yanni Wang; Yuwen Qiu; Junmin Shi; Hongling Zhou; Zibin Lu; Meng Shao; Linzhong Yu; Li Tong
Journal:  Cell Oncol (Dordr)       Date:  2016-03-25       Impact factor: 6.730

5.  Pien Tze Huang inhibits the proliferation of human colon carcinoma cells by arresting G1/S cell cycle progression.

Authors:  Aling Shen; Fei Hong; Liya Liu; Jiumao Lin; Lihui Wei; Qiaoyan Cai; Zhenfeng Hong; Jun Peng
Journal:  Oncol Lett       Date:  2012-07-19       Impact factor: 2.967

6.  Hedyotis diffusa willd extract suppresses colorectal cancer growth through multiple cellular pathways.

Authors:  Jianyu Feng; Yiyi Jin; Jun Peng; Lihui Wei; Qiaoyan Cai; Zhaokun Yan; Zijun Lai; Jiumao Lin
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

7.  Metabolomic Study on the Preventive Effect of Patrinia scabiosaefolia Fisch on Multipathogen Induced Pelvic Inflammatory Disease in Rats.

Authors:  Wei Zou; Xiaoke Wen; Yi Zheng; Zuoqi Xiao; Jieying Luo; Shuqiong Chen; Yichao Wang; Zeneng Cheng; Daxiong Xiang; Yichu Nie
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-14       Impact factor: 2.629

8.  Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.

Authors:  Jiumao Lin; Jianheng Zhou; Wei Xu; Xiaoyong Zhong; Zhenfeng Hong; Jun Peng
Journal:  Exp Ther Med       Date:  2013-03-15       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.